Literature DB >> 24962188

A principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysis.

Theresa L Chin1, Ernest E Moore2, Hunter B Moore1, Eduardo Gonzalez1, Michael P Chapman1, John R Stringham1, Christopher R Ramos1, Anirban Banerjee1, Angela Sauaia1.   

Abstract

INTRODUCTION: The mechanisms driving trauma-induced coagulopathy (TIC) remain to be defined, and its therapy demands an orchestrated replacement of specific blood products. Thrombelastography (TEG) is a tool to guide the TIC multicomponent therapy. Principal component analysis (PCA) is a statistical approach that identifies variable clusters; thus, we hypothesize that PCA can identify specific combinations of TEG-generated values that reflect TIC mechanisms.
METHODS: Adult trauma patients admitted from September 2010 to October 2013 for whom a massive transfusion protocol was activated were included. Rapid TEG values obtained within the first 6 hours after injury were included in the PCA. PCA components with an eigenvalue >1 were retained, and, within components, variable loadings (equivalent to correlation coefficients) >|60| were considered significant. Component scorings for each patient were calculated and clinical characteristics of patients with high and low scores were compared.
RESULTS: Of 98 enrolled patients, 67% were male and 70% suffered blunt trauma. Median age was 41 years (interquartile range 28-55) and median Injury Severity Score was 31.5 (interquartile range 24-43). PCA identified three principal components (PCs) that together explained 93% of the overall variance. PC1 reflected global coagulopathy with depletion of platelets and fibrinogen whereas PC3 indicated hyperfibrinolysis. PC2 may represent endogenous anticoagulants such as the activation of protein C.
CONCLUSION: PCA suggests depletion coagulopathy is independent from fibrinolytic coagulopathy. Furthermore, the distribution of mortality suggests that low levels of fibrinolysis may be beneficial in a select group of injured patients. These data underscore the potential of risk for concurrent presumptive treatment for preserved depletion coagulopathy and possible fibrinolysis.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24962188      PMCID: PMC4150833          DOI: 10.1016/j.surg.2014.04.030

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  26 in total

1.  Early coagulopathy predicts mortality in trauma.

Authors:  Jana B A MacLeod; Mauricio Lynn; Mark G McKenney; Stephen M Cohn; Mary Murtha
Journal:  J Trauma       Date:  2003-07

2.  Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study.

Authors:  Jonathan J Morrison; Joseph J Dubose; Todd E Rasmussen; Mark J Midwinter
Journal:  Arch Surg       Date:  2011-10-17

3.  Thrombocytopenia in cardiac surgery: diagnostic and prognostic importance.

Authors:  Ederlon Rezende; Gustavo Morais; João Manoel Silva Junior; Amanda Maria Ribas Rosa de Oliveira; Jose Marconi Almeida Souza; Diogo Oliveira Toledo; Ivo Richter; Enock Meira Brandão
Journal:  Rev Bras Cir Cardiovasc       Date:  2011 Jan-Mar

4.  Fresh frozen plasma should be given earlier to patients requiring massive transfusion.

Authors:  Ernest A Gonzalez; Frederick A Moore; John B Holcomb; Charles C Miller; Rosemary A Kozar; S Rob Todd; Christine S Cocanour; Bjorn C Balldin; Bruce A McKinley
Journal:  J Trauma       Date:  2007-01

5.  Blood transfusion. An independent risk factor for postinjury multiple organ failure.

Authors:  F A Moore; E E Moore; A Sauaia
Journal:  Arch Surg       Date:  1997-06

6.  Refractory postinjury thrombocytopenia is associated with multiple organ failure and adverse outcomes.

Authors:  Trevor L Nydam; Jeffery L Kashuk; Ernest E Moore; Jeffrey L Johnson; C Clay Burlew; Walter L Biffl; Carlton C Barnett; Angela Sauaia
Journal:  J Trauma       Date:  2011-02

7.  Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome.

Authors:  David A Schoenfeld; Gordon R Bernard
Journal:  Crit Care Med       Date:  2002-08       Impact factor: 7.598

8.  Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?

Authors:  Karim Brohi; Mitchell J Cohen; Michael T Ganter; Michael A Matthay; Robert C Mackersie; Jean-François Pittet
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

9.  A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study.

Authors:  Karen A Zink; Chitra N Sambasivan; John B Holcomb; Gary Chisholm; Martin A Schreiber
Journal:  Am J Surg       Date:  2009-05       Impact factor: 2.565

10.  Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients.

Authors:  John B Holcomb; Charles E Wade; Joel E Michalek; Gary B Chisholm; Lee Ann Zarzabal; Martin A Schreiber; Ernest A Gonzalez; Gregory J Pomper; Jeremy G Perkins; Phillip C Spinella; Kari L Williams; Myung S Park
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

View more
  32 in total

1.  Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.

Authors:  Gregory R Stettler; Ernest E Moore; Hunter B Moore; Geoffrey R Nunns; Julia R Coleman; Arthur Colvis; Arsen Ghasabyan; Mitchell J Cohen; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-09       Impact factor: 3.313

2.  [Uncritical use of tranexamic acid in trauma patients : Do no further harm!]

Authors:  M Maegele
Journal:  Unfallchirurg       Date:  2016-11       Impact factor: 1.000

Review 3.  Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications.

Authors:  Hunter B Moore; Ernest E Moore; Matthew D Neal; Forest R Sheppard; Lucy Z Kornblith; Dominik F Draxler; Mark Walsh; Robert L Medcalf; Mitch J Cohen; Bryan A Cotton; Scott G Thomas; Christine M Leeper; Barbara A Gaines; Angela Sauaia
Journal:  Anesth Analg       Date:  2019-09       Impact factor: 5.108

Review 4.  Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid.

Authors:  Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Michael P Chapman; Kirk C Hansen; Angela Sauaia; Christopher C Silliman; Anirban Banerjee
Journal:  J Trauma Acute Care Surg       Date:  2015-06       Impact factor: 3.313

5.  Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.

Authors:  Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal:  Transfusion       Date:  2016-04       Impact factor: 3.157

6.  Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage.

Authors:  Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Gregory Wiener; Michael P Chapman; Monika Dzieciatkowska; Angela Sauaia; Anirban Banerjee; Kirk C Hansen; Christopher Silliman
Journal:  J Am Coll Surg       Date:  2015-03-31       Impact factor: 6.113

7.  An International Normalized Ratio-Based Definition of Acute Traumatic Coagulopathy Is Associated With Mortality, Venous Thromboembolism, and Multiple Organ Failure After Injury.

Authors:  Ithan D Peltan; Lisa K Vande Vusse; Ronald V Maier; Timothy R Watkins
Journal:  Crit Care Med       Date:  2015-07       Impact factor: 7.598

8.  Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock.

Authors:  Hunter B Moore; Ernest E Moore; Peter J Lawson; Eduardo Gonzalez; Miguel Fragoso; Alex P Morton; Fabia Gamboni; Michael P Chapman; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal:  Surgery       Date:  2015-06-05       Impact factor: 3.982

9.  Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients.

Authors:  Hunter B Moore; Ernest E Moore; Ioannis N Liras; Eduardo Gonzalez; John A Harvin; John B Holcomb; Angela Sauaia; Bryan A Cotton
Journal:  J Am Coll Surg       Date:  2016-01-22       Impact factor: 6.113

10.  Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis.

Authors:  Hunter B Moore; Ernest E Moore; Benjamin R Huebner; Gregory R Stettler; Geoffrey R Nunns; Peter M Einersen; Christopher C Silliman; Angela Sauaia
Journal:  J Surg Res       Date:  2017-05-08       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.